The prognostic value of baseline clinical parameters in predicting the survival prolonging effect of radium-223-dichloride (223Ra)-therapy in metastatic castration resistant prostate cancer (mCRPC) patients is still an open issue. The aim of this study was investigating the impact of baseline quality of life (QoL) on overall survival (OS) in mCRPC patients treated with 223Ra. The present study also evaluated the trend of patient-reported QoL during both 223Ra-treatment and post-therapy follow-up period.
Baseline quality of life predicts overall survival in patients with mCRPC treated with 223Ra-dichloride / Frantellizzi, Viviana; De Feo, Maria Silvia; Di Rocco, Arianna; Pontico, Mariano; Pani, Arianna; Farcomeni, Alessio; Cosma, Laura; Lazri, Julia; De Vincentis, Giuseppe. - In: HELLENIC JOURNAL OF NUCLEAR MEDICINE. - ISSN 1790-5427. - 23:1(2020), pp. 12-20. [10.1967/s002449912001]
Baseline quality of life predicts overall survival in patients with mCRPC treated with 223Ra-dichloride
Frantellizzi, Viviana
Primo
;De Feo, Maria Silvia;Di Rocco, Arianna;Pontico, Mariano;Farcomeni, Alessio;Cosma, Laura;Lazri, Julia;De Vincentis, Giuseppe
2020
Abstract
The prognostic value of baseline clinical parameters in predicting the survival prolonging effect of radium-223-dichloride (223Ra)-therapy in metastatic castration resistant prostate cancer (mCRPC) patients is still an open issue. The aim of this study was investigating the impact of baseline quality of life (QoL) on overall survival (OS) in mCRPC patients treated with 223Ra. The present study also evaluated the trend of patient-reported QoL during both 223Ra-treatment and post-therapy follow-up period.| File | Dimensione | Formato | |
|---|---|---|---|
|
Frantellizzi_Baseline_2020.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.73 MB
Formato
Adobe PDF
|
1.73 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
